| Schedule of Segment Reporting Information, by Segment |
The following table is a comparative summary of the Company’s net sales and segment profit by reportable segment for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
| |
2022 |
2021 |
|
2022 |
|
2021 |
Segment Net Sales:
|
|
|
|
|
|
|
|
| Cannabinoid |
$ |
979
|
|
|
$ |
875 |
|
|
$ |
4,269
|
|
|
$ |
2,131 |
|
| Non-Cannabinoid |
2,326
|
|
|
3,156 |
|
|
8,917
|
|
|
9,049 |
|
| Total net sales |
3,305
|
|
|
4,031 |
|
|
13,186
|
|
|
11,180 |
|
| |
|
|
|
|
|
|
|
Segment Profit (Loss):
|
|
|
|
|
|
|
|
| Cannabinoid |
$ |
(4,395) |
|
|
$ |
(4,391) |
|
|
$ |
(17,421) |
|
|
$ |
(10,859) |
|
| Non-Cannabinoid |
95
|
|
|
551 |
|
|
1,109
|
|
|
1,797 |
|
| Total segment loss |
$ |
(4,300) |
|
|
$ |
(3,840) |
|
|
$ |
(16,312) |
|
|
$ |
(9,062) |
|
| |
|
|
|
|
|
|
|
Reconciliation:
|
|
|
|
|
|
|
|
| Total segment loss |
$ |
(4,300) |
|
|
$ |
(3,840) |
|
|
$ |
(16,312) |
|
|
$ |
(9,062) |
|
| Unallocated corporate expenses |
(1,425) |
|
|
(2,243) |
|
|
(6,802) |
|
|
(8,416) |
|
| Non-cash share-based compensation |
(958) |
|
|
(3,264) |
|
|
(2,606) |
|
|
(8,137) |
|
| Depreciation and amortization |
(508) |
|
|
(337) |
|
|
(1,562) |
|
|
(1,440) |
|
| Intangible asset impairment |
(19,000) |
|
|
— |
|
|
(19,000) |
|
|
— |
|
|
|
|
|
|
|
|
|
| Loss from operations |
$ |
(26,191) |
|
|
$ |
(9,684) |
|
|
$ |
(46,282) |
|
|
$ |
(27,055) |
|
| |
|
|
|
|
|
|
|
| Loss (gain) on debt extinguishment, net |
—
|
|
|
(3,375) |
|
|
2,263
|
|
|
(3,375) |
|
|
|
|
|
|
|
|
|
| Gain on remeasurement of warrant liability |
(196) |
|
|
(9,065) |
|
|
(2,009) |
|
|
(5,390) |
|
| Gain on investment |
—
|
|
|
— |
|
|
(6,851) |
|
|
— |
|
| Foreign exchange loss |
768
|
|
|
298 |
|
|
1,420
|
|
|
1,137 |
|
| Interest (income) expense and amortization of debt issuance cost |
(51) |
|
|
485 |
|
|
2,719
|
|
|
2,383 |
|
| Other expense (income), net |
101
|
|
|
964 |
|
|
111
|
|
|
(123) |
|
| (Loss) Income before income tax |
$ |
(26,813) |
|
|
$ |
1,009 |
|
|
$ |
(43,935) |
|
|
$ |
(21,687) |
|
|
| Disaggregation of Revenue |
The following table disaggregates the Company’s revenue by channel for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
| Mass retail |
$ |
2,008
|
|
|
$ |
1,958 |
|
|
$ |
7,243
|
|
|
$ |
5,567 |
|
| Distributors |
927
|
|
|
1,650 |
|
|
4,250
|
|
|
4,330 |
|
| Specialty, health and other retail |
282
|
|
|
277 |
|
|
1,234
|
|
|
852 |
|
| E-commerce |
88
|
|
|
146 |
|
|
459
|
|
|
431 |
|
| Total |
$ |
3,305
|
|
|
$ |
4,031 |
|
|
$ |
13,186
|
|
|
$ |
11,180 |
|
The following table represents the Company's revenues attributed to countries based on location of customer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|
2022 |
2021 |
2022 |
|
2021 |
| United States |
$ |
2,228
|
|
|
$ |
3,130 |
|
$ |
8,736
|
|
|
$ |
9,022 |
|
| Israel |
116
|
|
|
$ |
226 |
|
$ |
1,139
|
|
|
$ |
424 |
|
| Australia |
333
|
|
|
501 |
|
1,017
|
|
|
1,141 |
|
| Brazil |
249
|
|
|
1 |
|
1,169
|
|
|
147 |
|
| Germany |
360
|
|
|
25 |
|
912
|
|
|
25 |
|
| Other |
19
|
|
|
148 |
|
213
|
|
|
421 |
|
| Total |
$ |
3,305
|
|
|
$ |
4,031 |
|
$ |
13,186
|
|
|
$ |
11,180 |
|
|
| Schedule of Revenue by Major Customers by Reporting Segments |
During the nine months ended September 30, 2022 and 2021, the majority of the Company's net sales for the non-cannabinoid segment were in the U.S., with approximately $8.7 million of non-cannabinoid net sales.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of Revenues |
|
Percentage of Accounts Receivable |
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
September 30, |
|
December 31, |
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
| Customer A |
|
* |
|
* |
|
* |
|
* |
|
24% |
|
* |
Customer B (a)
|
|
17% |
|
15% |
|
12% |
|
17% |
|
10% |
|
25% |
Customer C (b)
|
|
* |
|
* |
|
* |
|
* |
|
20% |
|
18% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer E (b)
|
|
* |
|
* |
|
* |
|
* |
|
13% |
|
* |
* denotes less than 10%
(a) net sales attributed are reflected in the non-cannabinoid segments
(b) net sales attributed are reflected in the cannabinoid segments
|
| Long-lived Assets by Geographic Areas |
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
2022 |
|
December 31,
2021 |
Long-lived assets
|
|
|
|
| Colombia |
$ |
16,722
|
|
|
$ |
18,950 |
|
| Portugal |
12,087
|
|
|
11,733 |
|
Other(a)
|
187
|
|
|
249 |
|
| Total |
$ |
28,996
|
|
|
$ |
30,932 |
|
(a)“Other” includes long-lived assets primarily in the U.S.
|